Transplantation, ISSN 0041-1337, 07/2004, Volume 78, Issue 1, pp. 117 - 121
Background. The TNF2 allele at position -308 of the tumor necrosis factor (TNF)-alpha gene is associated with high TNF production. The purpose was to study the...
Complications of clinical transplantation | Hyperacute and acute rejection | Immunoresponse genes | Clinical transplantation | Kidney | Transplantation immunology and immunobiology | SURGERY | RENAL-TRANSPLANTATION | IMMUNOLOGY | RECIPIENTS | CYTOKINE GENE POLYMORPHISMS | TRANSPLANTATION | kidney | transplantation immunology and inummobiology | TUMOR-NECROSIS-FACTOR | ACUTE REJECTION | IMPACT | immunoresponse genes | EPISODES | clinical transplantation | hyperacute and acute rejection | complications of clinical transplantation | SECRETION | EXPRESSION | CYCLOSPORINE | Severity of Illness Index | Graft Rejection - drug therapy | Acute Disease | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Risk Factors | Tumor Necrosis Factor-alpha - genetics | Genotype | Male | Kidney Transplantation | Polymorphism, Genetic | Graft Rejection - epidemiology | Graft Survival - genetics | Female | Graft Rejection - genetics | Graft Rejection/drug therapy/epidemiology/genetics | Genetic | MEDICIN OCH HÄLSOVETENSKAP | Tumor Necrosis Factor-alpha/genetics | Graft Survival/genetics | Immunosuppressive Agents/therapeutic use | MEDICAL AND HEALTH SCIENCES | Polymorphism
Complications of clinical transplantation | Hyperacute and acute rejection | Immunoresponse genes | Clinical transplantation | Kidney | Transplantation immunology and immunobiology | SURGERY | RENAL-TRANSPLANTATION | IMMUNOLOGY | RECIPIENTS | CYTOKINE GENE POLYMORPHISMS | TRANSPLANTATION | kidney | transplantation immunology and inummobiology | TUMOR-NECROSIS-FACTOR | ACUTE REJECTION | IMPACT | immunoresponse genes | EPISODES | clinical transplantation | hyperacute and acute rejection | complications of clinical transplantation | SECRETION | EXPRESSION | CYCLOSPORINE | Severity of Illness Index | Graft Rejection - drug therapy | Acute Disease | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Risk Factors | Tumor Necrosis Factor-alpha - genetics | Genotype | Male | Kidney Transplantation | Polymorphism, Genetic | Graft Rejection - epidemiology | Graft Survival - genetics | Female | Graft Rejection - genetics | Graft Rejection/drug therapy/epidemiology/genetics | Genetic | MEDICIN OCH HÄLSOVETENSKAP | Tumor Necrosis Factor-alpha/genetics | Graft Survival/genetics | Immunosuppressive Agents/therapeutic use | MEDICAL AND HEALTH SCIENCES | Polymorphism
Journal Article
Mucosal Immunology, ISSN 1933-0219, 01/2016, Volume 9, Issue 1, pp. 171 - 182
Disruption of the homeostatic balance of intestinal dendritic cells (DCs) and macrophages (MQs) may contribute to inflammatory bowel disease. We characterized...
PATHOGENESIS | HOMEOSTASIS | DISPLAY | RETINOIC ACID | PATHWAY | GUT | INTESTINAL LAMINA PROPRIA | DIFFERENTIATION | IMMUNOLOGY | T-CELLS | BOWEL-DISEASE | Antigens, CD - immunology | Crohn Disease - genetics | Lymph Nodes - pathology | Dendritic Cells - immunology | Humans | Middle Aged | Colitis, Ulcerative - genetics | Dendritic Cells - pathology | Colon - immunology | Male | Antigens, CD - genetics | CD11c Antigen - immunology | Colitis, Ulcerative - immunology | Case-Control Studies | HLA-DR Antigens - genetics | CD11c Antigen - genetics | Intestinal Mucosa - immunology | Integrin alpha Chains - immunology | Aged, 80 and over | Adult | Female | Macrophages - immunology | Glycoproteins - genetics | Severity of Illness Index | Antigens, CD1 - immunology | Macrophages - pathology | Signal Transduction | Colon - pathology | Antigens, Surface - genetics | Gene Expression Regulation | Aldehyde Dehydrogenase - genetics | Lipopolysaccharide Receptors - immunology | Colitis, Ulcerative - pathology | Lymph Nodes - immunology | Crohn Disease - immunology | Glycoproteins - immunology | Crohn Disease - pathology | Adolescent | Lipopolysaccharide Receptors - genetics | Aged | HLA-DR Antigens - immunology | Aldehyde Dehydrogenase - immunology | Antigens, CD1 - genetics | Antigens, Surface - immunology | Integrin alpha Chains - genetics | Intestinal Mucosa - pathology | Clinical Medicine | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Gastroenterologi | Medicinska och farmaceutiska grundvetenskaper | Immunologi inom det medicinska området | Klinisk medicin | Gastroenterology and Hepatology | Immunology in the medical area
PATHOGENESIS | HOMEOSTASIS | DISPLAY | RETINOIC ACID | PATHWAY | GUT | INTESTINAL LAMINA PROPRIA | DIFFERENTIATION | IMMUNOLOGY | T-CELLS | BOWEL-DISEASE | Antigens, CD - immunology | Crohn Disease - genetics | Lymph Nodes - pathology | Dendritic Cells - immunology | Humans | Middle Aged | Colitis, Ulcerative - genetics | Dendritic Cells - pathology | Colon - immunology | Male | Antigens, CD - genetics | CD11c Antigen - immunology | Colitis, Ulcerative - immunology | Case-Control Studies | HLA-DR Antigens - genetics | CD11c Antigen - genetics | Intestinal Mucosa - immunology | Integrin alpha Chains - immunology | Aged, 80 and over | Adult | Female | Macrophages - immunology | Glycoproteins - genetics | Severity of Illness Index | Antigens, CD1 - immunology | Macrophages - pathology | Signal Transduction | Colon - pathology | Antigens, Surface - genetics | Gene Expression Regulation | Aldehyde Dehydrogenase - genetics | Lipopolysaccharide Receptors - immunology | Colitis, Ulcerative - pathology | Lymph Nodes - immunology | Crohn Disease - immunology | Glycoproteins - immunology | Crohn Disease - pathology | Adolescent | Lipopolysaccharide Receptors - genetics | Aged | HLA-DR Antigens - immunology | Aldehyde Dehydrogenase - immunology | Antigens, CD1 - genetics | Antigens, Surface - immunology | Integrin alpha Chains - genetics | Intestinal Mucosa - pathology | Clinical Medicine | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Gastroenterologi | Medicinska och farmaceutiska grundvetenskaper | Immunologi inom det medicinska området | Klinisk medicin | Gastroenterology and Hepatology | Immunology in the medical area
Journal Article
Immunity, Inflammation and Disease, ISSN 2050-4527, 06/2016, Volume 4, Issue 2, pp. 191 - 200
Several Butyrophilin (BTN) and Btn‐like (BTNL) molecules control T lymphocyte responses, and are genetically associated with inflammatory disorders and cancer....
irritable bowel syndrome (IBS) | ulcerative colitis (UC) | Butyrophilin (Btn)‐like (Btnl) | intestinal inflammation | colon cancer | immune regulation | Inflammatory bowel disease | Proteins | Sarcoidosis | Cytokines | Colorectal cancer | Irritable bowel syndrome | Inflammation | Gene expression | Experiments | Basic Medicine | Medical and Health Sciences | Butyrophilin (Btn)-like (Btnl) | Medicin och hälsovetenskap | Gastroenterologi | Immunologi inom det medicinska området | Klinisk medicin | Clinical Medicine | Medicinska och farmaceutiska grundvetenskaper | Gastroenterology and Hepatology | Immunology in the medical area
irritable bowel syndrome (IBS) | ulcerative colitis (UC) | Butyrophilin (Btn)‐like (Btnl) | intestinal inflammation | colon cancer | immune regulation | Inflammatory bowel disease | Proteins | Sarcoidosis | Cytokines | Colorectal cancer | Irritable bowel syndrome | Inflammation | Gene expression | Experiments | Basic Medicine | Medical and Health Sciences | Butyrophilin (Btn)-like (Btnl) | Medicin och hälsovetenskap | Gastroenterologi | Immunologi inom det medicinska området | Klinisk medicin | Clinical Medicine | Medicinska och farmaceutiska grundvetenskaper | Gastroenterology and Hepatology | Immunology in the medical area
Journal Article
Chemistry of Materials, ISSN 0897-4756, 05/2008, Volume 20, Issue 10, pp. 3480 - 3486
Journal Article
Chemistry of Materials, ISSN 0897-4756, 2009, Volume 20, Issue 10, p. 3480
In a systematic study, we investigate the effect of dopant level and hydration on the short-range structure of the proton-conducting perovskite-type oxide...
Condensed Matter Physics | Annan materialteknik | Other Materials Engineering | Other Engineering and Technologies not elsewhere specified | Övrig annan teknik | Den kondenserade materiens fysik
Condensed Matter Physics | Annan materialteknik | Other Materials Engineering | Other Engineering and Technologies not elsewhere specified | Övrig annan teknik | Den kondenserade materiens fysik
Journal Article
Chemistry of Materials, ISSN 0897-4756, 05/2008, Volume 20, Issue 10, pp. 3480 - 3486
In a systematic study, we investigate the effect of dopant level and hydration on the short-range structure of the proton-conducting perovskite-type oxide BaIn...
Ionic Conductors (including Solid (Inorganic) and Polymer Electrolytes) | Structural Characterization (including AFM, NMR, X-ray Diffraction, etc.)
Ionic Conductors (including Solid (Inorganic) and Polymer Electrolytes) | Structural Characterization (including AFM, NMR, X-ray Diffraction, etc.)
Journal Article
Journal of the Electrochemical Society, ISSN 0013-4651, 2008, Volume 155, Issue 11, p. 97
Journal Article
Surgical Innovation, ISSN 1071-5517, 03/2004, Volume 11, Issue 1, pp. 3 - 12
The advantages of laparoscopy in the treatment of benign disease have been well demonstrated. Compared to open surgery, laparoscopy is associated with a...
Colorectal Neoplasms - surgery | Treatment Outcome | Laparoscopy - methods | Humans | Colectomy - methods
Colorectal Neoplasms - surgery | Treatment Outcome | Laparoscopy - methods | Humans | Colectomy - methods
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or...
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article